Anaqua macht ausländische Patentanmeldungen zu einem strategischen Vorteil für IP-Profis
April 18, 2024 07:00 ET
|
Anaqua
BOSTON / MÜNCHEN, April 18, 2024 (GLOBE NEWSWIRE) -- Anaqua, der führende Anbieter von Innovations- und IP-Management-Technologien, kündigt die Weiterentwicklung seines Angebots für...
アナクアが外国特許出願を戦略的アドバンテージに変える 機能・サービス強化を発表
April 18, 2024 07:00 ET
|
Anaqua
ボストン, April 18, 2024 (GLOBE NEWSWIRE) --...
Anaqua transforme l’extension de brevets à l’international en avantage stratégique pour les professionnels de la PI
April 18, 2024 07:00 ET
|
Anaqua
BOSTON, 18 avr. 2024 (GLOBE NEWSWIRE) -- Anaqua, le leader des technologies de gestion de la propriété intellectuelle (PI) pour les entreprises, les conseils et les administrations, annonce...
Anaqua Transforms Foreign Patent Filing into a Strategic Advantage for Intellectual Property Professionals
April 18, 2024 07:00 ET
|
Anaqua
Anaqua revolutionizes IP management with enhanced Foreign Filing in AQX®, empowering swift global protection decisions.
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
April 16, 2024 08:00 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer...
Isuzu Motors Limited Drives Forward with Anaqua as Intellectual Property Management Provider
April 16, 2024 08:00 ET
|
Anaqua
Anaqua announces global commercial vehicle manufacturer Isuzu Motors as new intellectual property management software client.
PharmAla Announces Private Placement and Concurrent Debt Settlement
April 10, 2024 16:30 ET
|
PharmAla Biotech
PharmAla Initiates $750,000 Private Placement with concurrent debt settlement, anticipated to close on April 17th 2024
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
April 10, 2024 07:17 ET
|
Clearmind Medicine Inc.
Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a clinical- stage biotech company focused on discovery and...
Tome Biosciences Announces US Patent Issued for Integrase-Mediated Programmable Genomic Integration
April 09, 2024 08:08 ET
|
Tome Biosciences
Tome granted US patent for programmable genomic integration.
Anaqua Enhances AcclaimIP Patent Search with AI-Powered Capabilities
April 08, 2024 09:37 ET
|
Anaqua
Anaqua revolutionizes patent search with AI-powered AcclaimIP. Explore over 100M patents worldwide with user-friendly interface and cutting-edge AI.